Screener
Novavax NVAX Business Segments — Selling, general, and administrative
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Direct COVID-19 Vaccine(1) | 20,073 | 13,077 | 54,328 | 28,824 |
| Direct CIC and influenza vaccines | 703 | 7,117 | 3,556 | 19,621 |
| Direct other vaccine development programs(1) | 3,129 | 842 | 5,393 | 997 |
| Employee and benefit expenses | 30,820 | 36,149 | 68,875 | 76,060 |
| Facility and other research and development expenses(2) | 15,968 | 22,048 | 34,013 | 42,668 |
| Selling, general, and administrative expense | 26,665 | 43,612 | 55,442 | 91,702 |
| Other segment income (expense)(3) | 1,519 | 5,438 | 7,458 | 8,570 |
| Net income (loss) | $(53,387) | $106,508 | $(62,878) | $625,154 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's business segments — selling, general, and administrative?
- Novavax (NVAX) reported business segments — selling, general, and administrative of $26.67M in Q2 2026.
- How has Novavax's business segments — selling, general, and administrative changed year-over-year?
- Novavax's business segments — selling, general, and administrative decreased by 38.9% year-over-year, from $43.61M to $26.67M.
- What is the long-term trend for Novavax's business segments — selling, general, and administrative?
- Over 3 years (2022 to 2025), Novavax's business segments — selling, general, and administrative has grown at a -31.4% compound annual growth rate (CAGR), from $488.69M to $157.48M.
- What does business segments — selling, general, and administrative mean?
- Encompasses the operating expenses required to support the reportable segment's business activities, including marketing, sales, and general corporate overhead. It provides insight into the operational efficiency and the cost structure required to maintain the segment's market presence.
Ask your AI about Novavax's business segments — selling, general, and administrative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude